IMMUNOTOLERANCE INDUITE PAR S100A8/S100A9 CHEZ DES SUJETS NOUVEAU-NES

• 收藏
• 分享

专利权人:

WESTFALISCHE WILHELMS-UNIVERSITAT MUNSTER;MEDIZINISCHE HOCHSCHULE HANNOVER (MHH)

发明人:

VIEMANN, DOROTHEE,ROTH, JOHANNES,VOGL, THOMAS

申请号：

CA3040359

公开号：

CA3040359A1

申请日:

2017.11.06

申请国别(地区):

CA

年份:

2018

代理人:

摘要：

The present application provides for the use of S100A8 or S100A9 homodimer or S100A8/A9 heterodimer in the prevention or treatment of a NF-?B-associated postnatal inflammatory disorder in a newborn subject. Moreover, the present invention relates to a pharmaceutical composition comprising S100A8 or S100A9 homodimer or S100A8/A9 heterodimer and an in vitro method for evaluating the risk of a newborn subjectfor developing a NF-?B-associated postnatal inflammatory disorder.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/